5UWM
Matrix metalloproteinase-13 complexed with selective inhibitor compound (R)-17a
Summary for 5UWM
| Entry DOI | 10.2210/pdb5uwm/pdb |
| Related | 5UWK 5UWL 5UWN |
| Descriptor | Collagenase 3, ZINC ION, CALCIUM ION, ... (6 entities in total) |
| Functional Keywords | metalloproteinase, collagenase, mmp-13, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| Biological source | Homo sapiens (Human) More |
| Cellular location | Secreted, extracellular space, extracellular matrix : P45452 |
| Total number of polymer chains | 4 |
| Total formula weight | 41281.67 |
| Authors | Taylor, A.B.,Cao, X.,Hart, P.J. (deposition date: 2017-02-21, release date: 2017-07-12, Last modification date: 2023-10-04) |
| Primary citation | Choi, J.Y.,Fuerst, R.,Knapinska, A.M.,Taylor, A.B.,Smith, L.,Cao, X.,Hart, P.J.,Fields, G.B.,Roush, W.R. Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors. J. Med. Chem., 60:5816-5825, 2017 Cited by PubMed Abstract: We describe the use of comparative structural analysis and structure-guided molecular design to develop potent and selective inhibitors (10d and (S)-17b) of matrix metalloproteinase 13 (MMP-13). We applied a three-step process, starting with a comparative analysis of the X-ray crystallographic structure of compound 5 in complex with MMP-13 with published structures of known MMP-13·inhibitor complexes followed by molecular design and synthesis of potent but nonselective zinc-chelating MMP inhibitors (e.g., 10a and 10b). After demonstrating that the pharmacophores of the chelating inhibitors (S)-10a, (R)-10a, and 10b were binding within the MMP-13 active site, the Zn chelating unit was replaced with nonchelating polar residues that bridged over the Zn binding site and reached into a solvent accessible area. After two rounds of structural optimization, these design approaches led to small molecule MMP-13 inhibitors 10d and (S)-17b, which bind within the substrate-binding site of MMP-13 and surround the catalytically active Zn ion without chelating to the metal. These compounds exhibit at least 500-fold selectivity versus other MMPs. PubMed: 28653849DOI: 10.1021/acs.jmedchem.7b00514 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.62 Å) |
Structure validation
Download full validation report






